Page last updated: 2024-10-19

phenylpyruvic acid and Obesity

phenylpyruvic acid has been researched along with Obesity in 1 studies

phenylpyruvic acid: RN given refers to parent cpd
phenylpyruvate : A 2-oxo monocarboxylic acid anion resulting from deprotonation of the carboxy group of either keto- or enol-phenylpyruvic acid.
keto-phenylpyruvic acid : A 2-oxo monocarboxylic acid that is 3-phenylpropanoic acid substituted by an oxo group at position 2. It is an intermediate metabolite in the phenylalanine pathway.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AKISAWA, J1

Other Studies

1 other study available for phenylpyruvic acid and Obesity

ArticleYear
[CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 3. URINARY EXCRETION ON INTERMEDIARY METABOLITES OF TYROSINE IN PATIENTS WITH SOME ENDOCRINE DISEASES AND THE RELATED DISORDERS].
    Naika hokan. Japanese archives of internal medicine, 1964, Volume: 11

    Topics: Addison Disease; Biomedical Research; Diabetes Mellitus; Endocrine System Diseases; Humans; Hypercho

1964